Carlsmed, Inc. (CARL)
Carlsmed, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Carlsbad, CA, US. The stock last traded at $14.88, up 7.98% on the session, giving a market capitalisation of $404.5M. On trailing twelve-month figures it carries a trailing P/E of -10.94, a net margin of -57.4%. Its beta of 1.77 implies it has historically moved more than the broad market.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.